Marshall Wace
APYX icon

Marshall Wace’s Apyx Medical APYX Stock Holding History

Marshall Wace’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Buy
236,466
+174,630
+282% +$692K ﹤0.01% 2159
2026
Q1 		$228K Sell
61,836
-46,039
-43% -$172K ﹤0.01% 2732
2025
Q4 		$378K Buy
+107,875
New +$376K ﹤0.01% 2361
2024
Q1 		– Sell
-81,815
Closed -$214K – 2413
2023
Q4 		$214K Sell
81,815
-106,907
-57% -$259K ﹤0.01% 1964
2023
Q3 		$604K Buy
188,722
+120,763
+178% +$563K ﹤0.01% 1661
2023
Q2 		$342K Buy
+67,959
New +$344K ﹤0.01% 2104

Other funds holding APYX

RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Marshall Wace's APYX Position: Q2 2026 in Review

Marshall Wace increased its Apyx Medical (APYX) stake by 282% in Q2 2026, buying an estimated $692K and bringing the position to 236,466 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2159.

Marshall Wace first reported a position in APYX in Q2 2023 and has held it in 6 quarters since. 68 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

  • Marshall Wace held 236,466 shares of Apyx Medical worth $1.06M as of Q2 2026.
  • Marshall Wace bought 174,630 Apyx Medical shares in Q2 2026, an estimated $692K.
  • Apyx Medical made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2159 holding.
  • Marshall Wace first reported a position in Apyx Medical in Q2 2023 and has held it in 6 quarters since.
  • 68 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.